Bioceres Crop Solutions Corp. announced its financial results for the fiscal third quarter ended March 31, 2025, reporting total revenues of $60.6 million, a 28% decrease from $84.0 million in the prior year. The company recorded a net loss of $1.6 million, compared to a net income of $9.8 million in 3Q24, and Adjusted EBITDA declined by 57% to $9.0 million.
The revenue and gross profit declines were primarily related to the absence of a Syngenta downpayment accrual that had positively impacted 3Q24 results, as well as the usual third-quarter seasonal slowdown and reduced market activity in Argentina. Gross profit decreased by 44% to $23.8 million, and gross margin contracted to 39% from 51% year-over-year.
Despite the financial downturn, Bioceres demonstrated strong operating cash flow, with net cash flow from operating activities reaching $23.3 million, a $40.7 million increase compared to the year-ago quarter. This improvement was primarily driven by disciplined inventory and accounts receivables management, with the cash used to reduce financial debt and bolster the cash position.
The company also continued its strategic shift in the seed business, exchanging some non-core traits and intellectual property, streamlining third-party royalty commitments, and reducing operating expenses by transferring seed production and commercialization activities to key customers. These actions contributed $7.5 million to Other Income during the quarter. The EPA registration of Rinotec was also highlighted as a significant achievement during this period.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.